Ariachery C Ammini
All India Institute of Medical Sciences
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ariachery C Ammini as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:22 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT00814372 · Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on MetforminGilead Sciences · terminated · Type 2 Diabetes Mellitus · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:22 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:22 UTC. The ranking covers the 200 most relevant of 5 PubMed records, and a shared surname and initials can bring in a namesake. All 5 on PubMed
- Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study.J Clin Endocrinol Metab · 2004103 citationsRCR 3.2
- 65 citationsRCR 2.5
- Negative correlation between negative symptoms of schizophrenia and testosterone levels.Ann N Y Acad Sci · 200464 citationsRCR 2.0
- Comparison of gliclazide with insulin as initial treatment modality in newly diagnosed type 2 diabetes.Diabetes Technol Ther · 200813 citationsRCR 0.4
- Graves' Disease during pregnancy--results of antithyroid drug therapy.Singapore Med J · 19992 citationsRCR 0.1